14th Annual School of Breast Oncology Online
WebcastFaculty
OVERVIEW
14th Annual School of Breast Oncology Online is organized by Physicians Education Resource, LLC (PER) and would be held during Feb 10, 2017 - Feb 10, 2018.
The target audience for this medical event for directed toward medical oncologists, fellows, surgical oncologists, and radiation oncologists who treat patients with breast cancer. This CME Conference has been approved with a maximum of 25.00 AMA PRA Category 1 Credits.
Conference Objectives are :
At the conclusion of this activity, participants should be better prepared to :
• Review breast cancer pathology, tumor biology, and prognostic/predictive markers in order to stratify risk among patients with breast cancer.
• Discuss currently accepted diagnostic standards and imaging modalities for breast cancer.
• Integrate biomarkers, molecular assays, and other risk assessment tools into clinical practice to optimize clinical decision making for patients with breast cancer.
• Describe current treatment standards concerning the use of surgical, radiation, and medical therapies for patients with breast cancer.
• Describe strategies for the management of early stage or locally advanced breast cancer.
• Review methods to individualize the application of systemic therapies for patients with advanced breast cancer.
• Discuss strategies to proactively mitigate predictable treatment-related toxicities to optimize outcomes for patients with breast cancer.
• Determine recent practice-changing results from clinical trials and facilitate discussions with patients concerning their eligibility for clinical trial opportunities.
Additional details will be posted as soon as they are available.
The target audience for this medical event for directed toward medical oncologists, fellows, surgical oncologists, and radiation oncologists who treat patients with breast cancer. This CME Conference has been approved with a maximum of 25.00 AMA PRA Category 1 Credits.
Conference Objectives are :
At the conclusion of this activity, participants should be better prepared to :
• Review breast cancer pathology, tumor biology, and prognostic/predictive markers in order to stratify risk among patients with breast cancer.
• Discuss currently accepted diagnostic standards and imaging modalities for breast cancer.
• Integrate biomarkers, molecular assays, and other risk assessment tools into clinical practice to optimize clinical decision making for patients with breast cancer.
• Describe current treatment standards concerning the use of surgical, radiation, and medical therapies for patients with breast cancer.
• Describe strategies for the management of early stage or locally advanced breast cancer.
• Review methods to individualize the application of systemic therapies for patients with advanced breast cancer.
• Discuss strategies to proactively mitigate predictable treatment-related toxicities to optimize outcomes for patients with breast cancer.
• Determine recent practice-changing results from clinical trials and facilitate discussions with patients concerning their eligibility for clinical trial opportunities.
Additional details will be posted as soon as they are available.
SPECIALITIES
Oncology
Quick Links